Literature DB >> 26629009

Accuracy of serum interleukin (IL)-6 in sepsis diagnosis: a systematic review and meta-analysis.

Tieying Hou1, Dehong Huang2, Rong Zeng3, Zhiming Ye4, Yu Zhang1.   

Abstract

OBJECTIVE: To systematic review and estimate the accuracy of Interleukin 6 assay in the diagnosis of sepsis by meta-analysis.
METHODS: With the aim to confirm this correlation, this paper performed a meta-analysis of 6 studies and the Sensitivity, specificity, positive likelihood ratio (PLR), and negative likelihood ratio (NLR) with corresponding 95% confidence intervals (CI) of each study were calculated and the pooled sensitivity was calculate using Random Effects Model and Summary receiver operating characteristic curves were constructed.
RESULTS: The pooled sensitivity for the diagnosis of sepsis was 80% (95% CI, 77% to 83%) and the specificity of 85% (95% CI, 81% to 88%). For sepsis versus health or infection, the area under the curve was 0.868. In neonate subgroup, IL-6 had a pooled sensitivity of 77.0% (95% CI, 73.0% to 81.0%) and specificity of 91.0% (95% CI, 86.0% to 94.0%) for sepsis diagnosis. In adult, IL-6 had a pooled sensitivity of 85.0% (95% CI, 80.0% to 88.0%) and specificity of 62.0% (95% CI, 55.0% to 68.0%) to identify sepsis. The AUC was 81.0%, and Q was 0.74.
CONCLUSIONS: IL6 is a highly accurate diagnostic modality for the identification of sepsis, with promise for integration into routine imaging protocols for thyroid nodules.

Entities:  

Keywords:  IL-6; SROC; Sepsis; diagnosis; meta-analysis

Year:  2015        PMID: 26629009      PMCID: PMC4658898     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  20 in total

1.  Assessment of pro-vasopressin and pro-adrenomedullin as predictors of 28-day mortality in septic shock patients.

Authors:  Caroline Guignant; Nicolas Voirin; Fabienne Venet; Françoise Poitevin; Christophe Malcus; Julien Bohé; Alain Lepape; Guillaume Monneret
Journal:  Intensive Care Med       Date:  2009-08-07       Impact factor: 17.440

Review 2.  Presepsin as a novel sepsis biomarker.

Authors:  Qi Zou; Wei Wen; Xin-Chao Zhang
Journal:  World J Emerg Med       Date:  2014

3.  Discriminative value of inflammatory biomarkers for suspected sepsis.

Authors:  Ephraim L Tsalik; L Brett Jaggers; Seth W Glickman; Raymond J Langley; Jennifer C van Velkinburgh; Lawrence P Park; Vance G Fowler; Charles B Cairns; Stephen F Kingsmore; Christopher W Woods
Journal:  J Emerg Med       Date:  2011-11-06       Impact factor: 1.484

4.  Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis.

Authors:  M Oberhoffer; W Karzai; A Meier-Hellmann; D Bögel; J Fassbinder; K Reinhart
Journal:  Crit Care Med       Date:  1999-09       Impact factor: 7.598

5.  Disease progression in hemodynamically stable patients presenting to the emergency department with sepsis.

Authors:  Seth W Glickman; Charles B Cairns; Ronny M Otero; Christopher W Woods; Ephraim L Tsalik; Raymond J Langley; Jennifer C van Velkinburgh; Lawrence P Park; Lawrence T Glickman; Vance G Fowler; Stephen F Kingsmore; Emanuel P Rivers
Journal:  Acad Emerg Med       Date:  2010-04       Impact factor: 3.451

Review 6.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-03-28       Impact factor: 17.440

7.  Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines.

Authors:  A Viallon; F Zeni; V Pouzet; C Lambert; S Quenet; G Aubert; S Guyomarch; B Tardy; J C Bertrand
Journal:  Intensive Care Med       Date:  2000-08       Impact factor: 17.440

8.  Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency department.

Authors:  Martijn D de Kruif; Maarten Limper; Herman Gerritsen; C Arnold Spek; Dees P M Brandjes; Hugo ten Cate; Patrick M Bossuyt; Pieter H Reitsma; Eric C M van Gorp
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

9.  Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis.

Authors:  Ville Pettilä; Marja Hynninen; Olli Takkunen; Pentti Kuusela; Matti Valtonen
Journal:  Intensive Care Med       Date:  2002-07-19       Impact factor: 17.440

10.  Plasma transforming growth factor-beta1 level in patients with severe community-acquired pneumonia and association with disease severity.

Authors:  Huang-Pin Wu; Chian-Kuang Chen; Kong Chung; Bor-Yiing Jiang; Teng-Jen Yu; Duen-Yau Chuang
Journal:  J Formos Med Assoc       Date:  2009-01       Impact factor: 3.282

View more
  27 in total

1.  PI3K/AKT and CD40L Signaling Regulate Platelet Activation and Endothelial Cell Damage in Sepsis.

Authors:  Peng Wan; Xiang Tan; Yan Xiang; Huasheng Tong; Min Yu
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

2.  Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults.

Authors:  Daniel Molano Franco; Ingrid Arevalo-Rodriguez; Marta Roqué I Figuls; Nadia G Montero Oleas; Xavier Nuvials; Javier Zamora
Journal:  Cochrane Database Syst Rev       Date:  2019-04-30

3.  Lactobacillus rhamnosus GG Ameliorates Liver Injury and Hypoxic Hepatitis in Rat Model of CLP-Induced Sepsis.

Authors:  Lei Ding; Yihang Gong; Zhengfei Yang; Baojia Zou; Xialei Liu; Baimeng Zhang; Jian Li
Journal:  Dig Dis Sci       Date:  2019-04-30       Impact factor: 3.199

4.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  Acute Med Surg       Date:  2018-02-05

Review 5.  Mass spectrometry for the discovery of biomarkers of sepsis.

Authors:  Katelyn R Ludwig; Amanda B Hummon
Journal:  Mol Biosyst       Date:  2017-03-28

6.  Sepsis Biomarkers.

Authors:  Yachana Kataria; Daniel Remick
Journal:  Methods Mol Biol       Date:  2021

7.  The predictive role of Interleukin 6 in burn patients with positive blood cultures.

Authors:  Jochen Gille; Jovan Jocovic; Thomas Kremer; Armin Sablotzki
Journal:  Int J Burns Trauma       Date:  2021-04-15

8.  A network medicine approach to investigation and population-based validation of disease manifestations and drug repurposing for COVID-19.

Authors:  Yadi Zhou; Yuan Hou; Jiayu Shen; Reena Mehra; Asha Kallianpur; Daniel A Culver; Michaela U Gack; Samar Farha; Joe Zein; Suzy Comhair; Claudio Fiocchi; Thaddeus Stappenbeck; Timothy Chan; Charis Eng; Jae U Jung; Lara Jehi; Serpil Erzurum; Feixiong Cheng
Journal:  PLoS Biol       Date:  2020-11-06       Impact factor: 8.029

9.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  J Intensive Care       Date:  2018-02-02

10.  Atomic Scale Interactions between RNA and DNA Aptamers with the TNF-α Protein.

Authors:  Homayoun Asadzadeh; Ali Moosavi; Georgios Alexandrakis; Mohammad R K Mofrad
Journal:  Biomed Res Int       Date:  2021-07-16       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.